Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Top Cited Papers

1 February 2002

journal article
research article
Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology

Vol. 20 (3) , 719-726
https://doi.org/10.1200/jco.20.3.719

Abstract

PURPOSE: To evaluate the efficacy and safety of first-line, single-agent trastuzumab in women with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS: One hundred fourteen women wit...

Keywords

TREATMENT
OVEREXPRESSION
EFFICACY
TRASTUZUMAB
METASTATIC BREAST
BREAST CANCER
MG/KG
HER2 OVEREXPRESSING
SAFETY